Dementia risk assessment and risk reduction using cardiovascular risk factors

Area of Science:

• Neurology
• Cardiology
• Public Health

Background:

• Alzheimer's Disease (AD) poses a significant burden, with limited effective treatments.
• Disease-modifying treatments for AD are lacking, prompting a shift towards midlife preventative strategies.
• Cardiovascular risk factors are implicated in up to one-third of all dementia cases.

Purpose of the Study:

• To compare emerging evidence for dementia risk assessment using cardiovascular factors with existing cardiovascular risk assessment tools.
• To investigate the potential of using cardiovascular risk assessment for dementia prevention in primary care settings.
• To guide future research on integrating dementia risk reduction into cardiovascular risk management.

Main Methods:

• Reviewing emerging evidence on dementia risk assessment and reduction via cardiovascular risk factors.
• Comparing this evidence with the supporting evidence for the QRISK3 cardiovascular disease risk calculator.
• Analyzing the application of lifestyle modifications and lipid-lowering therapies based on risk scores.

Main Results:

• Emerging evidence suggests cardiovascular risk factors can predict future dementia risk.
• The QRISK3 tool is established for cardiovascular disease risk assessment and intervention in the UK.
• Lifestyle changes and lipid-modifying therapy are recommended based on QRISK3 scores.

Conclusions:

• Cardiovascular risk assessment shows promise for identifying individuals at risk of future dementia.
• Further research is needed to validate the use of cardiovascular risk assessment for dementia risk reduction strategies.
• Integrating dementia risk assessment into primary care cardiovascular risk management could enhance preventative healthcare.